DMX-1001 (oral noribogaine) is a novel neuroplastogen therapeutic that combines neuroplasticity and polypharmacology for the treatment of AUD AUD affects more than 29 million Americans and is a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results